Overview
Hans-hilmar Goebel practices in Berlin, Germany. Goebel is rated as an Experienced expert by MediFind in the treatment of Hereditary Ataxia. Their top areas of expertise are Myositis, Necrotizing Myopathy (NM), Inclusion Body Myositis, and Dermatomyositis.
Their clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hereditary Ataxia.
Locations
Mainz, RP, Germany
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MyositisGoebel isDistinguished. Learn about Myositis.
- Advanced
- Cramp-Fasciculation Syndrome
- DermatomyositisGoebel isAdvanced. Learn about Dermatomyositis.
- Inclusion Body MyositisGoebel isAdvanced. Learn about Inclusion Body Myositis.
- Necrotizing Myopathy (NM)Goebel isAdvanced. Learn about Necrotizing Myopathy (NM).
- PolymyositisGoebel isAdvanced. Learn about Polymyositis.
- Experienced
- Batten DiseaseGoebel isExperienced. Learn about Batten Disease.
- Becker Muscular DystrophyGoebel isExperienced. Learn about Becker Muscular Dystrophy.
- Cerebral HypoxiaGoebel isExperienced. Learn about Cerebral Hypoxia.
- CLN1 DiseaseGoebel isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseGoebel isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseGoebel isExperienced. Learn about CLN3 Disease.